Topadur Pharma AG
8952 Schlieren, Grabenstrasse 11a
A team dedicated to develop innovative speciality medication for the treatment of severe wound-healing problems enabling significant improvements of patients quality of life. TOPADUR’s lead R&D programs are local active, highly potent, dual mode of action drugs. TOPADUR’s unique development candidates #3;work on validated drug targets resulting in higher than average clinical success chances.
Topadur Pharma AG
Grabenstrasse 11a
8952 Schlieren
Trias Pharma GmbH
8406 Winterthur, Technoparkstrasse 2 / Trakt B, 4. OG, Büro 4206/4207
Pharmazeutische Entwicklung, orale Darreichungsformen, Beratung
Trias Pharma GmbH
Technoparkstrasse 2
8406 Winterthur